Aquatic Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.3M	Buy	+31,061	New	+$10.6M	0.3%	84
2025 Q4	–	Sell	-84,059	Closed	-$38.3M	–	1378
2025 Q3	$38.3M	Buy	+84,059	New	+$34.2M	0.71%	22
2025 Q2	–	Sell	-14,348	Closed	-$3.87M	–	1221
2025 Q1	$3.87M	Sell	14,348 -26,204	-65%	-$6.73M	0.1%	265
2024 Q4	$9.54M	Buy	40,552 +20,143	+99%	+$5.3M	0.26%	100
2024 Q3	$5.61M	Buy	20,409 +17,209	+538%	+$4.48M	0.15%	171
2024 Q2	$778K	Sell	3,200 -18,600	-85%	-$2.94M	0.03%	450
2024 Q1	$3.26M	Buy	21,800 +900	+4%	+$150K	0.11%	186
2023 Q4	$4M	Buy	20,900 +3,000	+17%	+$511K	0.1%	204
2023 Q3	$3.17M	Buy	+17,900	New	+$3.42M	0.13%	171
2023 Q2	–	Sell	-21,300	Closed	-$4.27M	–	1297
2023 Q1	$4.27M	Buy	+21,300	New	+$4.48M	0.26%	105
2022 Q2	–	Sell	-200	Closed	-$33K	–	1167
2022 Q1	$33K	Buy	+200	New	+$30.5K	0.05%	373